Floatz logo

Lipitor

Mild Cognitive Impairment

Johns Hopkins UniversityPhase 4 / ApprovedActive
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
55/ 100
Competitive Position
73/ 100

Competitive context

98 Active assets in the Mild Cognitive Impairment cohort.

Asset / SponsorPhaseRating
Sra-333
Helse Stavanger HF
Phase 4BBB
Metformin
Fudan University
Phase 4BB
Ginkgo Biloba Extract
Hanyang University
Phase 4BB
Ginkgo Biloba
Dr. Willmar Schwabe GmbH & Co. KG
Phase 4BB
Methylphenidate
St. Jude Children's Research Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Lipitor is also rated in:

inherited lipid metabolism disorderDormant
A
Indicative ·
83 / 100
View asset →
hyperlipidemiaDormant
BBB
Indicative ·
79 / 100
View asset →
HypercholesterolemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →